[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Science indicates less severe omicron disease", "description": "Omicron symptoms, Headache, Fatigue, Runny nose, Sore throat, Sneezing\n\nhttps://www.youtube.com/watch?v=WH7ISb-ReAo\n\nhttps://covid.joinzoe.com\n\nFever, cough, anosmia less common\n\nHeadache,  65%\n\nFatigue,   65%\n\nRunny nose, 65%\n\nSore throat,  57%\n\nSneezing,  55%\n\nThe Australia experiment\n\nhttps://www.reuters.com/business/healthcare-pharmaceuticals/australia-push-ahead-with-reopening-amid-record-covid-19-cases-2022-01-03/?utm_source=Sailthru&utm_medium=email&utm_term=The%20Reuters%20Daily%20Briefing&utm_content=3-1-21&utm_campaign=3-1-21\n\nRecord infections\n\nPlans to reopen economy\n\nPrime Minister Scott Morrison\n\nWe have to stop thinking about case numbers and think about serious illness,\n\nliving with the virus, \n\nmanaging our own health and ensuring that we're monitoring those symptoms \n\nand we keep our economy going\n\nhttps://www.theguardian.com/australia-news/2022/jan/03/all-of-us-are-going-to-be-exposed-to-omicron-queensland-chief-health-officer-warns\n\nQueensland, chief health officer, Dr John Gerrard\n\nOmicron, peak at very large numbers in late January or early February\n\nWe are expecting in the next few weeks very substantial numbers of people are going to be infected \n\nI think we just have to assume that all of us are going to be exposed in the next few weeks\n\nwe can expect very large numbers of cases\nand in the majority of cases, \n\nthe vast majority of cases, \nthe symptoms will be mild\n \nSo clearly the vaccine is working\n\nQueensland premier, Annastacia Palaszczuk\n\nWhat we\u2019re doing is telling people to go and get vaccinated. \n\nWe have \u2026 given every Queenslander in this state the opportunity to get vaccinated\n\nI\u2019m now urging people in those Indigenous communities to ignore those social media posts and immediately go and get your vaccination\n\n\nSARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo \n\nhttps://www.researchsquare.com/article/rs-1189219/v1\n\nOmicron infects and multiplies 70 times faster than the Delta in human bronchus\n\nOmicron variant replicated 10 times less in human lung tissue than the original SARS-CoV-2 virus \n\nSARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19\n\nhttps://www.biorxiv.org/content/10.1101/2021.12.26.474085v2\n\nMice infected with Delta compared to mice infected with Omicron\n\nLess severe clinical signs (weight loss)\n\nLower virus loads\n\nLess extensive inflammation in the lungs\n\nT cell epitopes probably conserved\n\nClinical consequences of infection with the \nOmicron variant may be less severe,\n\nbut the higher transmissibility could still place huge burden upon healthcare systems\n\n\n\nThe omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters\n\nhttps://www.biorxiv.org/content/10.1101/2021.12.24.474086v1\n\nAll other SARS-CoV-2 VoCs replicate efficiently in Syrian hamsters\n\nIn hamsters that had been infected with omicron, a 3 log10 lower viral RNA load was detected in the lungs\n\nNo infectious virus was detectable in the lungs\n\nHistopathological examination, lungs from omicron-infected hamsters, no signs pneumonia. \n\n\n\n\n\n\n\n\n\n\nThe SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters \n\nhttps://www.researchsquare.com/article/rs-1211792/v1\n\nB.1.1.529 Omicron isolates\n\nImmunocompetent and human ACE2 (hACE2) \n\nExpressing mice and hamsters\n\nAttenuated lung disease\n\nNot as ill\n\nLower viral loads\n\n\n\nSARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells\n\nhttps://www.embopress.org/doi/full/10.15252/embj.20105114\n\nThe hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism \n\nhttps://www.gla.ac.uk/researchinstitutes/iii/cvr/engage/news/headline_829358_en.html\n\nhttps://www.gla.ac.uk/media/Media_829360_smxx.pdf\n\nOmicron, markedly decreased neutralisation in serology\n\nIn order\n\nThree doses of vaccine\n\nImmunity from natural infection (without vaccination)\n\nTwo doses of vaccine\n\nOmicron, compared to Delta and Wuhan D614G\n\nTitres of the Omicron variant in lung tissue,\n\nwere at least an order of magnitude lower at each time point compared to the other two variants\n\nThis is consistent with attenuated replication of Omicron in lower respiratory tissues as recently reported", "link": "https://www.youtube.com/watch?v=1avXjzr1xnc", "date_published": "2022-01-03 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Omicron is displacing delta science", "description": "Omicron infection also produced immunity against Delta. This means someone who has been infected with delta is largely immune to subsequent delta infection. Therefore delta will soon have no one to infect, therefore will go away.\n\nOmicron infection enhances neutralizing immunity against the Delta variantOmicron infection enhances neutralizing immunity against the Delta variant\n \nhttps://www.ahri.org/wp-content/uploads/2021/12/MEDRXIV-2021-268439v1-Sigal_corr.pdf\n\nAfrica Health Research Institute, Durban, South Africa\n\nSchool of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal\n\nOmicron has been shown to be highly transmissible\n\nOmicron has extensive evasion of neutralizing antibody immunity,\n\nelicited by vaccination and previous SARS-CoV-2 infection. \n\nOmicron infections are rapidly expanding worldwide often in the face of high levels of Delta infections. \n\nQuestion\n\nDo omicron antibodies neutralise delta virus variant?\n\nDoes neutralizing immunity elicited by Omicron also enhances neutralizing immunity against the Delta variant?\n\nMethod\n\nIsolated the omicron and delta virus\n\nTested these against the plasma of 15 confirmed omicron cases\n\nUsed a live virus neutralization assay\n(Vero E6 cells were propagated in complete growth medium) \n\nCalculated the focus reduction neutralization test (FRNT50) \n\nVolunteers\n\nPreviously vaccinated\n\nUnvaccinated individuals who were infected with SARS-CoV-2 in the Omicron infection wave\n\nRecruited soon after symptom onset\n \nWe then measured their ability to neutralize both Omicron and Delta virus at enrolment,\n\nversus a median of 14 days after enrolment. \n\nNeutralization of Omicron increased 14-fold over this time,\n \nshowing a developing antibody response to omicron\n\nAlso\nEnhancement of Delta virus neutralization, increased 4.4-fold. \n\nTherefore\n\nThe increase in Delta variant neutralization in individuals infected with Omicron may result in decreased ability of Delta to re-infect\n\nAlso\n\nEmerging data indicating that Omicron is less pathogenic than Delta\n\nTherefore\n\nCross immunity from omicron to delta may have positive implications in terms of decreasing the Covid-burden of severe disease. \n\nMore science\nThe ability of one variant to elicit immunity which can cross-neutralize another variant varies by variant\n\nImmunity elicited by Delta infection\n\nDoes not cross-neutralize Beta virus\n\nImmunity elicited by Beta infection\n\nDoes not cross-neutralize Delta well \n\nParticipants in this study\n\nMany probably previously infected\n\nMore than half were vaccinated\n\nTherefore  activation of antibody immunity from previous infection and/or vaccination is possible\n\nImplications\n\nThese results are consistent with Omicron displacing the Delta variant\n\nAs cross immunity makes re-infection with Delta less likely\n\n(But previous delta exposure will not protect from symptomatic omicron infection)\n\nIf indeed Omicron is less pathogenic than Delta\n\nThe incidence of Covid-19 severe disease would be reduced\n\nInfection may shift to become less disruptive to individuals and society", "link": "https://www.youtube.com/watch?v=PYLbJ0H8zdc", "date_published": "2022-01-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]